New research advances understanding of Parkinson's disease stages
From a study that analyzed brain images of more than 2,500 people with Parkinson's disease in 20 different countries, scientists were able to identify patterns of neurodegeneration and create metrics ...
drugtargetreview.com9d
Landmark study aims to detect Parkinson’s before symptoms
Grifols' Chronos-PD initiative leverages its plasma repository to identify biomarkers for Parkinson’s disease.
GEN2d
Cholesterol Metabolite Implicated in Parkinson’s Disease Pathology
Researchers suggest drugs that prevent cholesterol from being converted to 24-OHC might therefore be an effective treatment for Parkinson's disease.
Too Old to Operate7d
In Parkinson’s Disease, Talk Therapy Addresses Unmet Psychological Needs
In a recent study, talk therapy in Parkinson’s disease led to significant improvement in patients' well-being, problems/symptoms, and functioning.
Cambridge Scientists Develop Brain Implants To Treat Parkinson’s Damage
Cambridge researchers are developing implants to help repair brain pathways damaged by Parkinson’s disease. As part of a £69 ...
中国日报网18h
Target protein could slow progression of Parkinson's
Researchers at Shanghai Huashan Hospital have identified a novel therapeutic target that could lead to the world's first treatment to slow the progression of Parkinson's disease.
AskBio Receives FDA Regenerative Medicine Advanced Therapy designation for Parkinson’s disease investigational gene therapy
Berlin, Germany, and Research Triangle Park, N.C., USA, Feb. 19, 2025 (GLOBE NEWSWIRE) -- Not intended for UK MediaRegenerative Medicine ...
Knowridge13d
A new wearable treatment for Parkinson’s motor fluctuations
The U.S. Food and Drug Administration (FDA) has approved Onapgo (apomorphine hydrochloride) injection, the first and only ...
Medindia8d
FDA-Approved Parkinson's Drug Could Alleviate Nicotine Withdrawal Symptoms
Procyclidine shows promise in reducing nicotine withdrawal symptoms, providing a potential new option for smoking cessation ...
Pharmabiz1d
AskBio’s gene therapy AB-1005 to treat Parkinson’s disease receives US FDA Regenerative Medicine Advanced Therapy designation
AskBio’s gene therapy AB-1005 to treat Parkinson’s disease receives US FDA Regenerative Medicine Advanced Therapy designation: Berlin, Germany Thursday, February 20, 2025, 10: ...